Skip to main
DLB
DLB logo

Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories (DLB) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 36%
Buy 18%
Hold 36%
Sell 0%
Strong Sell 9%

Bulls say

Dolby Laboratories Inc. reported a 13% year-over-year increase in total revenue, largely driven by a 12.5% rise in License Revenue, which constitutes 93% of its overall earnings. The company anticipates continuing growth from its Atmos and Vision technologies, projecting a 15% increase in fiscal year 2025, supported by expanding adoption across various devices. With end market demand stabilizing after several challenging years and additional growth potential from the recent acquisition of GE Licensing, Dolby is well-positioned for ongoing revenue enhancement as it increases its screen footprint and optimizes its royalty capabilities.

Bears say

Dolby Laboratories Inc's outlook appears negative due to anticipated declines in key segments, particularly in broadcast, where lower set-top-box shipments and difficult year-over-year comparisons from COVID-related impacts are expected to hinder growth. The company's guidance for fiscal 2025 indicates flat revenues relative to 2024, further compounded by ongoing challenges related to semiconductor availability and supply chain disruptions that could limit product integration. These factors collectively suggest potential difficulties in achieving meaningful revenue and profit growth in the near term.

Dolby Laboratories (DLB) has been analyzed by 11 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 18% recommend Buy, 36% suggest Holding, 0% advise Selling, and 9% predict a Strong Sell.

This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Dolby Laboratories (DLB) Forecast

Analysts have given Dolby Laboratories (DLB) a Buy based on their latest research and market trends.

According to 11 analysts, Dolby Laboratories (DLB) has a Buy consensus rating as of Jul 12, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $66.36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $66.36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Dolby Laboratories (DLB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.